Slides
Page 1
BGT GT BIOPHARMA Tri - Specific NK Cell ENGAGERS ( TriKE® ) Targeted NK Cell Therapies to Treat Cancer and Autoimmune Disease GT Biopharma ( Nasdaq : GTBP ) Corporate Presentation – August 2026 -
Loading workspace
BGT GT BIOPHARMA Tri - Specific NK Cell ENGAGERS ( TriKE® ) Targeted NK Cell Therapies to Treat Cancer and Autoimmune Disease GT Biopharma ( Nasdaq : GTBP ) Corporate Presentation – August 2026 -
Your watchlist and earnings event details are available after you sign in.